- Home
- CSIQ vs ORGO Comparison
CSIQ vs ORGO Comparison
Compare CSIQ & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSIQ
- ORGO
- Stock Information
- Founded
- CSIQ 2001
- ORGO 1985
- Country
- CSIQ Canada
- ORGO United States
- Employees
- CSIQ N/A
- ORGO N/A
- Industry
- CSIQ Semiconductors
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- CSIQ Technology
- ORGO Health Care
- Exchange
- CSIQ Nasdaq
- ORGO Nasdaq
- Market Cap
- CSIQ 475.1M
- ORGO 533.9M
- IPO Year
- CSIQ 2006
- ORGO N/A
- Fundamental
- Price
- CSIQ $10.11
- ORGO $3.01
- Analyst Decision
- CSIQ Hold
- ORGO Buy
- Analyst Count
- CSIQ 10
- ORGO 2
- Target Price
- CSIQ $17.54
- ORGO $5.50
- AVG Volume (30 Days)
- CSIQ 2.5M
- ORGO 2.2M
- Earning Date
- CSIQ 05-15-2025
- ORGO 05-08-2025
- Dividend Yield
- CSIQ N/A
- ORGO N/A
- EPS Growth
- CSIQ N/A
- ORGO N/A
- EPS
- CSIQ 0.54
- ORGO N/A
- Revenue
- CSIQ $5,993,409,000.00
- ORGO $458,760,000.00
- Revenue This Year
- CSIQ $23.74
- ORGO $3.31
- Revenue Next Year
- CSIQ $16.57
- ORGO $12.50
- P/E Ratio
- CSIQ $18.80
- ORGO N/A
- Revenue Growth
- CSIQ N/A
- ORGO 5.35
- 52 Week Low
- CSIQ $6.57
- ORGO $2.17
- 52 Week High
- CSIQ $21.05
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- CSIQ 57.36
- ORGO 30.72
- Support Level
- CSIQ $8.84
- ORGO $2.88
- Resistance Level
- CSIQ $11.33
- ORGO $5.55
- Average True Range (ATR)
- CSIQ 0.73
- ORGO 0.40
- MACD
- CSIQ 0.15
- ORGO -0.23
- Stochastic Oscillator
- CSIQ 50.58
- ORGO 4.87
About CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar power company. It is an integrated provider of solar power products, services, and system solutions. The company engages in designing, developing, and manufacturing solar ingots, wafers, cells, modules, and other solar power products. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. Its Recurrent segment primarily comprises solar and battery storage project development and sale, O&M and asset management services for operational projects, sale of electricity, and investment in retained assets.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.